We are in a revolutionary new era of immunotherapy for skin cancers where immunotherapy has opened the doors to find additional treatment options for advanced and unresectable skin cancers. This paradigm shift in skin cancer treatment is demanding dermatology providers to better understand about immunotherapy. Therefore, the goal of this presentation is to facilitate understanding of various types of immunotherapy and their potential side effects in the treatment of melanoma and non-melanoma skin cancers.
Describe the various types of immunotherapeutic agent
Identify two key indications for delivery of skin directed and systemic therapies in patients with persistent/progressive CTCL, elaborating safety monitoring requirements.
City of Hope National Medical Center
You must be logged in and own this session in order to